Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease
2011 ◽
Vol 93
(8)
◽
pp. 705-715
◽
2006 ◽
Vol 2006
◽
pp. 260-261
◽
2009 ◽
Vol 91
(11)
◽
pp. 2748
◽
Keyword(s):